Stem cells produce blood vessels using novel vasculogenic method

07/30/2013 | MedicalXpress.com

Researchers at Massachusetts General Hospital and Harvard University were able to produce endothelial cells and multipotent stromal cells from human induced pluripotent stem cells and use them to generate blood vessels in vivo. "To our knowledge, this is the first report demonstrating the use of triple selection markers CD34, NP1 and KDR for the isolation of vasculogenic precursor cells from human induced pluripotent stem cells that are, most importantly, highly potent in an in vivo setting," according to one of the researchers.

View Full Article in:

MedicalXpress.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Confidential
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations